The cutting-edge companies we focus on range from those delivering therapeutic or diagnostic benefits to patients to those disrupting the status quo in healthcare and accelerating the pace of innovation.
When it is time to execute, we are disciplined but decisive. Experience and analysis both support our dynamic decision-making processes and help us know when to pull the trigger.
We leverage our robust network of industry colleagues to proactively generate multiple paths of optionality for our companies throughout their journeys.
First, we aim to invest in the highest quality science and teams, with the biggest potential impact for patients. Then, we focus on building excellent companies that drive to value inflection with speed and efficiency.
Every aspect of our work is oriented toward advancing human medicine. Our mission is to build transformational companies that benefit patients and the professionals who serve them.
We thrive on taking calculated risks. We invest in big, new ideas with breakthrough potential
Beyond capital, we assist with team recruitment, portfolio strategy, business development, regulatory and clinical planning, and much more. We roll up our sleeves to help our companies get it done.
Based in the Research Triangle, we are a leader in the Southeast while maintaining a robust North American investment footprint.
With over 25 years and 100 companies under our belts, we have demonstrated we deliver value.